Orchid Pharma has informed that the Extraordinary General Meeting (EGM) of the Company was held on June 29, 2021 at 11:30 am through Video conference (VC)/ Other Audio-Visual Means (OAVM). In this regard, the company has enclosed the voting results along with the consolidated report of the Scrutinizer for both remote E-Voting and E-Voting as required under Regulation 44 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations 2015.
The above information is a part of company’s filings submitted to BSE.
